CD274 and non-small cell lung carcinoma: In the context of NSCLC, higher TMB levels often correlate with robust immune cell infiltration and a heightened T cell–mediated inflammatory response, resulting in increased sensitivity to PD-1/PD-L1 blockade—an effect that can manifest even in tumors with otherwise low PD-L1 expression [16].